AGIO
Agios Pharmaceuticals, Inc.
32.60$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -833.1% | -1,020.5% | -1,219.5% | -842.6% | -939.5% | -1,241.1% | -1,277.7% | -619.2% | -684.4% | -481.9% | -573.2% | -128.1% | -366.7% | |
| 21.9% | 19.8% | 16.5% | 18.5% | 15.0% | 12.7% | 14.6% | 10.1% | 10.7% | 6.3% | 6.6% | 3.0% | 5.4% | |
| 122.7% | 194.5% | 112.8% | 134.2% | 124.3% | 101.6% | 130.2% | 118.0% | 96.1% | 70.7% | 74.9% | 35.6% | 59.0% | |
| 415.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -36.5% | 78.8% | -354.0% | 117.5% | 505.9% | -431.1% | -418.3% | 66.5% | -1.8% | -23.0% | -187.0% | -2.3% | -45.4% | |
| 5.0% | 3.3% | 1.7% | 1.8% | 4.7% | 9.0% | 8.8% | 7.0% | 12.1% | 5.6% | 3.7% | 2.7% | 4.7% | |
| 531.7% | 1,344.7% | 1,521.1% | 432.3% | 2,797.8% | -458.1% | 1,290.2% | 634.0% | 741.9% | 451.1% | 681.2% | 89.9% | 373.4% | |
| 25.4% | 11.9% | 71.6% | 12.8% | 29.4% | 45.1% | 18.6% | 0.5% | 34.4% | 12.8% | 10.0% | 7.0% | 12.4% | |
| -276.0% | 336.1% | 373.2% | -397.5% | 1,887.7% | -1,654.1% | 31.1% | 15.3% | 91.9% | -17.9% | 118.0% | -31.2% | 19.1% | |
| -838.1% | -1,023.8% | -1,221.2% | -844.4% | -944.2% | -1,250.1% | -1,286.4% | -626.2% | -696.5% | -487.5% | -576.9% | -130.8% | -371.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.